Health & Nutrition

bg
U.S. investors, Big Pharma race to find new medicines in China

U.S. investors, Big Pharma race to find new medicines in...

U.S. investors and large pharmaceutical companies are increasingly doing deals in...

bg
Prenuvo adds new health tests to flagship full-body scan, raises $120 million in fresh funding

Prenuvo adds new health tests to flagship full-body scan,...

Prenuvo exploded in popularity because of its $2,500 full-body MRI scan that has...

bg
Moderna beats on revenue but loses more than expected as it scales down manufacturing

Moderna beats on revenue but loses more than expected as...

It marks another quarter of growing pains for the company, which is racing to launch...

bg
CVS shares are up 45% this year — here's why it may be starting to turn its business around

CVS shares are up 45% this year — here's why it may be...

Some analysts are more optimistic about CVS' ability to navigate higher-than-expected...

bg
Is Sorghum a Healthy Grain? 

Is Sorghum a Healthy Grain? 

How does sorghum compare with other grains in terms of protein, antioxidants, and...

bg
We're adding to our position in a sliding stock and booking profits in a 2025 winner

We're adding to our position in a sliding stock and booking...

We're making a pair of trades Monday as Wall Street rallies to kick off the week.

bg
Ozempic (Semaglutide) and Other GLP-1 Weight-Loss Drugs: Their Uses, Side Effects, and More

Ozempic (Semaglutide) and Other GLP-1 Weight-Loss Drugs:...

Ozempic and others in a new class of weight-loss drugs have been called “the medical...

bg
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma

Trump is unlikely to end Medicare drug price talks — here's...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical...

bg
Doximity shares pop 36% on revenue beat, rosy guidance

Doximity shares pop 36% on revenue beat, rosy guidance

The company built a digital platform for medical professionals that can help them...

bg
Hims & Hers faces scrutiny from senators on Super Bowl ad that 'risks misleading' patients

Hims & Hers faces scrutiny from senators on Super Bowl...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing...